<DOC>
	<DOCNO>NCT01336348</DOCNO>
	<brief_summary>This single-centre , open-label prospective randomize pharmacodynamic investigation 2 antiplatelet regimen patient undergo coronary intervention ST segment elevation myocardial infarction ( STEMI ) : 1 . Tirofiban bolus bolus follow 2 hour infusion top 600 mg clopidogrel 60 mg prasugrel . 2 . Prasugrel give 60 mg .</brief_summary>
	<brief_title>Facilitation Through Aggrastat By drOpping Shortening Infusion Line Patients With ST-segment Elevation Myocardial Infarction Compared Top PRasugrel Loading dOse</brief_title>
	<detailed_description>Primary hypothesis : Percentage IPA 20uMol/ADP 30 ' superior tirofiban arm ( aggregate ) versus prasugrel alone arm Percentage IPA 30 ' 20uMol/ADP 90 % ±15 80 % ±15 tirofiban prasugrel alone arm , respectively . For power 90 % alpha error set 5 % , 50 patient per group recruit .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>Chest pain &gt; 30 min electrocardiographic STsegment elevation 1 mm two contiguous electrocardiogram ( ECG ) lead , new leave bundlebranch block , admission either within 12 h symptom onset 12 24 h onset evidence continue ischemia Administration fibrinolytic GP IIbIIIa inhibitor treatment current AMI within 1 month history bleed diathesis Known sensitivity abciximab , component product murine monoclonal antibody Major surgery trauma within 30 day Active bleed Previous stroke last six month Oral anticoagulant therapy Preexisting thrombocytopenia Vasculitis Hypertensive retinopathy Severe hepatic failure Severe renal failure require haemodialysis Documented allergy/intolerance contraindication clopidogrel inability assume clopidogrel consecutive daily basis minimum 30 day , heparin aspirin Uncontrolled hypertension ( systolic diastolic arterial pressure &gt; 180 mmHg 120 , respectively , despite medical therapy ) Limited life expectancy , e.g . neoplasm , others Inability obtain informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Prasugrel</keyword>
	<keyword>Tirofiban</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>glycoprotein IIa/IIIa inhibitor</keyword>
	<keyword>P2Y12 blocker</keyword>
</DOC>